Home 2018
Archives
Prognostic Model Developed for Immunotx of Urothelial Cancer
Model, based on six factors, predicts overall survival for patients treated with atezolizumab
Atezolizumab + Bevacizumab Shows Benefit in Met Renal CA
Progression-free survival benefit for patients with untreated metastatic renal cell carcinoma
Apalutamide Active in Castration-Resistant Prostate Cancer
Apalutamide prolongs metastasis-free survival in non-metastatic castration-resistant prostate cancer
Very Low-Calorie Diet Prompts Brief Heart Function Drop
44 percent rise in myocardial triglyceride content; tied to reduction in systolic, diastolic function
Decreased Survival When Surgery Refused for Esophageal Cancer
Worse median survival when refusing recommended surgery versus choosing surgery, neoadjuvant tx
CABG May Be Better Than PCI for 3-Vessel Dz in Younger Adults
PCI had higher MI, repeat revascularization, adverse CV and cerebrovascular risks in patients ≤50 years
Obesity, Metabolic Syndrome Ups Risk of Recurrent Prostate Cancer
Following radical prostatectomy, higher BMI increases risk of recurrence for prostate cancer
ASA: High Adherence to MIND Diet May Benefit Stroke Survivors
Following the diet is associated with a slower rate of global cognitive decline among stroke survivors
Sleep Duration, Cycle Linked to Childhood Body Weight
Shorter sleep duration, more fragmented circadian rhythms, increased intradaily variability tied to BMI
Body Fat Linked to Breast Cancer Risk in Normal-BMI Women
High whole-body, trunk fat mass tied to higher risk of ER-positive breast cancer in postmenopausal women
